List of All Articles with Tag 's'

F1 commentator Jack Nicholls has lost his job at BBC Radio 5 Live after complaints of “inappropriate touching” which led to his dismissal from his lead commentator role with Formula E. An investigation was launched by Formula E after a formal complaint of inappropriate behaviour in March and allegations of “inappropriate touching” were made by three individuals, one of whom had been in a relationship with the commentator. Now Nicholls, who combined his role with Formula E alongside commentating on F1 races for 5 Live, has also lost his job with IMG, who provide radio F1 coverage for the BBC. An IMG spokesperson confirmed to The Independent on Friday: “IMG has decided to part ways with Jack Nicholls in light of the incidents that led to his departure from Formula E.” After losing his job at Formula E at the end of May, Nicholls said: “Although disappointed with the decision, I respect it and accept why it was taken. “I want to take full responsibility for what I did and apologise unreservedly for a couple of isolated incidents that has made those concerned feel uncomfortable. “I never meant any harm and I am committed to making amends and to be more mindful of my behaviour in future.” Nicholls’ voice is synonymous with Formula E with his “and we go green…” intro to races well-known to fans since the championship began in 2014. But since the investigation, Nicholls had commentated on FE races remotely from a base in London, with Ben Edwards replacing him for the double-header in Jakarta two weeks ago and for the remaining five races of this season. Nicholls combined this role with F1 commentary for the BBC, a job he has performed since 2016, but he stepped aside from scheduled appearances at the Monaco Grand Prix three weeks ago after the Formula E investigation had concluded. The commentator has also appeared on Netflix’s popular behind-the-scenes F1 show Drive to Survive. Rosanna Tennant, Harry Benjamin and Oliver Askew will be the team on hand providing BBC’s radio coverage of the Canadian Grand Prix this weekend. Read More Sky suspend F1 pundits after sexist comments live on air Ferrari’s F1 flaws all the more baffling after shock success at Le Mans Sergio Perez ‘under threat’ at Red Bull with young star tipped to replace him Ferrari’s F1 flaws all the more baffling after shock success at Le Mans Mercedes chief predicts performance level at Canadian Grand Prix

New research suggests testosterone replacement therapy is safe for men with “low T” and who have cardiovascular disease or are at high risk for it

One of the scientists whose work pioneered the development of medications such as Ozempic and Wegovy has revealed why life may become “so miserably boring” after two years of using the drug. Ozempic is an FDA-approved medication used for the treatment of type 2 diabetes. It works by mimicking a hormone called glucagon-like peptide 1 (GLP-1), which regulates blood sugar levels and slows down the rate at which food leaves the stomach, often creating the feeling of fullness. These semaglutide injections – sold under the brand names Ozempic and Wegovy – have soared in popularity as many people, including Hollywood celebrities, have used it for weight loss. What’s more, people have also found Ozempic has been effective in curing their addictive habits, like drinking, smoking, shopping, or nail biting. However, because of Ozempic’s increasing popularity, it has led to national shortages of the type 2 diabetes treatment – leaving those who actually need it without. In an interview with Wired, professor Jens Juul Holst – who received the Warren Alpert Foundation Prize in 2021 for his work developing treatments based on the GLP-1 hormone – spoke about the effects of Ozempic, and why he believes many people will stop taking the medication after just a few years. “What happens is that you lose your appetite and also the pleasure of eating, and so I think there’s a price to be paid when you do that,” Holst told Wired. “If you like food, then that pleasure is gone. The craving for food for some people is taken away when they take GLP-1 drugs.” He continued: “That may eventually be a problem, that once you’ve been on this for a year or two, life is so miserably boring that you can’t stand it any longer and you have to go back to your old life.” Holst added that medications like Ozempic and Wegovy have been on the market since 2005, though studies show that these people don’t stay on them for very long. “It’s just like every other drug, they don’t stay on it for many reasons,” he explained. “One of the reasons, as I said, is that once you have tried it and you realise you’ve lost interest in food, then that may be enough.” “We don’t know why people stop taking these drugs, but we know for a fact that they do stop. They do that all over the world.” A 2020 study found that 70 per cent of people who took GLP-1 drugs for type 2 diabetes stopped taking them within two years. However, this could pose a problem for many patients taking semaglutide injections. Research has found that people who stopped taking Ozempic or Wegovy for weight loss experienced weight rebound. A trial published in April 2022 saw participants gain back two thirds of the weight they had lost after 68 weeks of taking semaglutide. As for celebrities who use the once-weekly injection for weight loss, despite not having diabetes or clinical obesity, Hans instead called attention to the “many terrible problems” that those with diabetes have struggled with by not having drugs like Ozempic readily available. “Have you ever visited a diabetes hospital? It’s really deplorable,” he said. “People come in with amputated limbs and compromised cognitive functions and heart problems or they can barely move – they’re miserable and depressed. It’s really serious. There is so much you can improve with a drug that is not only a weight-loss drug but is also an anti-diabetic.” Amidst the popularity of semaglutide injections, the US Food and Drug Administration has issued warnings for consumers not to use off-brand versions of Ozempic or Wegovy, because they may not include the same GLP-1 hormone used in approved medications. Earlier this month, agency officials reported problems with patients using compounded versions of semaglutide – which combines traditional semaglutide with other ingredients. These drugs are not FDA-approved, and the agency does not verify the safety or effectiveness of compounded drugs. Consumers should only use drugs containing semaglutide with a prescription from a licensed health care provider and obtained from a state-licensed pharmacy or other facilities registered with the FDA, the agency said. Read More What is ‘Ozempic face’? Doctors warn about facial ageing side effect of diabetes medications How does Wegovy work? The ‘game changing’ weight loss drug beloved by Hollywood FDA warns against using off-brand versions of Ozempic, Wegovy for weight loss Pregnant Stassi Schroeder admits she wants to ‘try’ Ozempic after giving birth Doctors warn about ‘Ozempic face’ side effect of medications Amy Schumer says she stopped taking Ozempic because of side-effects

The cries of adoring fans filled the air as stars like actor Jacob Elordi and Italian singer Elodie arrived for the Valentino show, which opened Milan Fashion Week menswear previews on Friday

The tough, stuck-on messes on your baking sheets require aggressive cleaning products.

Have you been stewing because Safari’s address bar seems to have disappeared from your new

Pokemon didn't invent the monster-catching role-playing game, but it's the biggest name in the genre.

In his obituaries, Cormac McCarthy has been widely praised as a descendant of William Faulkner and Herman Melville among others, those excavators of the American spirit whose biblically influenced prose raised narratives to tragic and poetic heights

The Notes app built into Apple devices has long offered people a quick and convenient

By Arriana McLymore NEW YORK Amazon is excluding its new competitor Temu from its price searching algorithm that

After years of demonising billionaire investor George Soros as a sinister liberal bogeyman, the Hungarian government and its allied media are taking aim at a...

Playboy ever-so-sneakily entered the sex toy market earlier this year by partnering with Lovers, a